CT70 and diabetes mellitus: In the present study, plasma LeXis was significantly upregulated in NASH and was also found to be a specific biomarker for NASH diagnosis in patients with NAFLD, regardless of other clinical factors such as hypertension and diabetes, or the levels of aminotransferase, creatinine, and platelets.